Quote | Mosaic ImmunoEngineering Inc (OTCMKTS:PTSCD)
Last: | $3.74 |
---|---|
Change Percent: | 24.67% |
Open: | $3.25 |
Close: | $3.74 |
High: | $3.74 |
Low: | $3.1 |
Volume: | 1,007 |
Last Trade Date Time: | 12/30/2020 04:55:15 pm |
News | Mosaic ImmunoEngineering Inc (OTCMKTS:PTSCD)
NOVATO, CA / ACCESSWIRE / December 30, 2020 / Mosaic ImmunoEngineering Inc., (the "Company" or "Mosaic") (OTC PINK:PTSCD), a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious dise...
-Preclinical Data Published in Peer Reviewed Journals Support Advancing the Program into Human Clinical Trials- -Company Plans to Initiate Discussions with Regulatory Agencies in Early 2021 to Review Its Strategy for IND or Equivalent Filing- -Data Generated in Companion Animals wi...
Message Board Posts | Mosaic ImmunoEngineering Inc (OTCMKTS:PTSCD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Mosaic ImmunoEngineering Inc Company Name:
PTSCD Stock Symbol:
OTCMKTS Market:
NOVATO, CA / ACCESSWIRE / December 30, 2020 / Mosaic ImmunoEngineering Inc., (the "Company" or "Mosaic") (OTC PINK:PTSCD), a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious dise...
-Preclinical Data Published in Peer Reviewed Journals Support Advancing the Program into Human Clinical Trials- -Company Plans to Initiate Discussions with Regulatory Agencies in Early 2021 to Review Its Strategy for IND or Equivalent Filing- -Data Generated in Companion Animals wi...